Spectrofluorimetric determination of aliskiren in tablets and spiked human plasma through derivatization with dansyl chloride

Journal of Fluorescence

Volumn 22, Issue 2, 2012, Pages 549-556

  Aydoǧmuş, Zeynep ^a   Sari, Ferhat ^a   Ulu, Sevgi Tatar ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Aliskiren; Dansyl chloride; Spectrofluorimetry; Spiked plasma; Tablets

Indexed keywords

ALISKIREN; BICARBONATE SOLUTION; CALIBRATION CURVES; CONCENTRATION RANGES; DANSYL CHLORIDE; DERIVATIZATIONS; DOSAGE FORMS; EXPERIMENTAL PARAMETERS; LIMITS OF DETECTION; PLASMA SAMPLES; REACTION PATHWAYS; SENSITIVE METHOD; SPECTROFLUORIMETRIC DETERMINATION; SPECTROFLUORIMETRY; SPIKED HUMAN PLASMAS; STANDARD SOLUTIONS; TABLETS;

DICHLOROMETHANE;

PLASMAS;

ALISKIREN; AMIDE; DANSYL CHLORIDE; FUMARIC ACID DERIVATIVE;

ARTICLE; BLOOD; CALIBRATION; CHEMISTRY; HUMAN; PH; SENSITIVITY AND SPECIFICITY; SPECTROFLUOROMETRY; TABLET; ULTRAVIOLET SPECTROPHOTOMETRY;

AMIDES; CALIBRATION; DANSYL COMPOUNDS; FUMARATES; HUMANS; HYDROGEN-ION CONCENTRATION; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS;

EID: 84862194723     PISSN: 10530509     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10895-011-0988-y     Document Type: Article

References (19)

1. Huang HL, Vaidyanathan S, Yeh CM, Bizot MN, Dieterich HA, Dole WP, Howard D. Effect of aliskiren, an oral direct renin inhibitor, on the pharmacokinetics and pharmacodynamics of a single dose of acenocoumarol in healthy volunteers. Curr Med Res Opin 24:2449-2456
2. Limoges D, Dieterich HA, Yeh CM, Vaidyanathan S, Howard D, Dole WP (2008) A study of dose-proportionality in the pharmacokinetics of the oral direct renin inhibitor aliskiren in healthy subjects. Int J Clin Pharmacol Ther 46:252-258 (Pubitemid 351663162)
3. Zhao C, Vaidyanathan S, Yeh CM, Maboudian M, Armin Dieterich H (2006) Aliskiren exhibits similar pharmacokinetics in healthy volunteers and patients with type 2 diabetes mellitus. Clin Pharmacokinet 45:1125-1134 (Pubitemid 44631391)
4. Lefévre G, Duval M, Poncin A (2000) Direct microradioimmunoassay of the new rennin inhibitor CGP 60536. J Immunoassay 21:65-84 (Pubitemid 30249577)
5. Lefevre G, Gauron S (2000) Automated quantitative determination of the new rennin inhibitor CGP 60536 by high-performance liquid chromatography. J Chromatogr B 738:129-136 (Pubitemid 30053100)
6. Dieterle W, Corynen S, Vaidyanathan S, Mann J (2005) Pharmacokinetic interactions of the oral renin inhibitor aliskiren with lovastatin, atenolol, celecoxib and cimetidine. Int J Clin Pharmacol Ther 43:527-535 (Pubitemid 41684265)
7. Vaidyanathan S, Valencia J, Kemp C, Zhao C, Yeh CM, Bizot MN, Denouel J, Dieterich HA, Dole WP (2006) Lack of pharmacokinetic interactions of aliskiren, a novel direct rennin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers. Int J Clin Pract 60:1343-1356 (Pubitemid 44560330)
8. Ayalasomayajula S, Tchaloyan S, Yeh CM, Bizot MN, Dieterich HA, Howard D, Dole WP (2008) A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with allopurinol, celecoxib and cimetidine in healthy subjects. Curr Med Res Opin 224:717-726 (Pubitemid 351428984)
9. Vaidyanathan S, Bigler H, Yeh C, Bizot MN, Dieterich HA, Howard D, Dole WP (2007) Pharmacokinetics of the oral direct renin inhibitor aliskiren alone and in combination with irbesartan in renal impairment. Clin Pharmacokinet 46:661-675 (Pubitemid 47204852)
10. Wrasse-Sangoi M, Secretti LT, Diefenbach IF, Rolim CMB, Sangoi MD (2010) Development and validation of an UV spectrophotometric method for the determination of aliskiren in tablets. Quim Nova 33:1330-1334
11. Pachauri S, Paliwal S, Srinivas KS, Singh Y, Jain V (2010) Development and validation of HPLC method for analysis of some antihypertensive agents in their pharmaceutical dosage forms. J Pharm Sci Res 2:459-464
12. AyadMM, el-HayMH(1984)Spectrofluorimetricmicro-determination of imidazoline derivatives using 1-dimethylaminonaphthalene-5-sulphonyl chloride.Analyst109:1431-1434 (Pubitemid 15211416)
13. Bartzatt R (2003) Dansylation of aromatic, aliphatic and medicinal carboxylic acid compounds in 1M Na2CO3 buffer. Anal Chim Acta 488:203-209 (Pubitemid 36851588)
14. Ma Y, Xiang F, Jin W, Yu L (2010) Determination of total glutathione in yeasts by highperformance liquid chromatography with dansylation. Z Naturforsch C 65:391-394
15. El-Enany N, Belal F, Rizk M (2008) Spectrofluorimetric determination of oxamniquine in dosage forms and spiked human plasma through derivatization with 1 dimethylaminonaphthalene-5-sulphonyl chloride. J Fluoresc 18:349-355
16. Zhuang XM, Yuan M, Zhang ZW, Wang XY, Zhang ZQ, Ruan JX (2008) Determination of 4-dimethylaminophenol concentrations in dog blood using LC-ESI/MS/MS combined with precolumn derivatization. J Chromatogr B Analyt Technol Biomed Life Sci 876:76-82
17. Cruces-Blanco C, Segura Carretero A, Merino Boyle E, Fernández GA (1999) The use of dansyl chloride in the spectrofluorimetric determination of the synthetic antioxidant butylated hydroxyanisole in foodstuffs. Talanta 50:1099-1108
18. Job P (1928) Formation and stability of inorganic complexes in solution. Anal Chem 9:113-203
19. Coates, J. (2000). Encyclopedia of analytical chemistry: interpretation of infrared spectra, a practical approach. R.A. Meyers (Ed.), John Wiley and Sons Ltd, Chichester. pp. 10815-10837